In brain tissues from MS patients, transporter GLT-1 is found to be downregulated (Vercellino et al., 2007) — suggesting an altered glutamate reuptake in the synaptic cleft—in the presence of activated microglia and myelin and neuronal damage (Vercellino et al., 2007). Here, SLC1A2 is linked to myeloid sarcoma.